GKOS.NYSEGlaukos CORP

Form 4: Glaukos CFO Alex Thurman Awarded Performance Options

Sentiment:

Insider Transaction (Form 4)


Glaukos Corporation's SVP & CFO, Alex R. Thurman, was awarded 3,660 stock options following the achievement of operational targets.

Better than expectedThe vesting of 3,660 stock options for the SVP & CFO indicates the company successfully met pre-determined operational targets.The Compensation, Nominating & Governance Committee's approval confirms the achievement of these internal performance metrics.

Summary

  • SVP & CFO Alex R. Thurman was awarded 3,660 stock options on December 11, 2025.
  • These options are a portion of a grant originally made on March 24, 2022, which vested due to Glaukos Corporation achieving pre-determined operational targets.
  • The Compensation, Nominating & Governance Committee of the Issuer's Board of Directors confirmed the achievement of these targets.
  • The stock options have an exercise price of $55.18.
  • The total number of derivative securities beneficially owned by Mr. Thurman after this transaction is 37,510, which includes a de minimis adjustment to correct a previously reported mathematical error.

Sentiment

Score: 8

Explanation: The vesting of performance-based options indicates the company met its operational targets, which is a positive sign for internal performance and executive incentives.

Positives

  • Glaukos Corporation achieved pre-determined operational targets, leading to the vesting of executive stock options.
  • The Compensation, Nominating & Governance Committee's determination confirms strong company performance against internal metrics.

Future Outlook

The acquired stock options are subject to a future vesting schedule, with 50% becoming exercisable in March 2026 and the remaining 50% in December 2026, indicating future milestones for the executive's compensation.

Management Comments

  • The Compensation, Nominating & Governance Committee of the Issuer's Board of Directors determined that certain pre-determined operational targets had been achieved, leading to the vesting of a portion of the stock option award.

Industry Context

This Form 4 filing details an insider transaction related to executive compensation, a common practice across all industries where performance-based incentives are used to align management interests with company goals.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Compensation Committee ActionThe Compensation, Nominating & Governance Committee determined that pre-determined operational targets were achieved, leading to the vesting of performance-based stock options.12/11/2025Reflects standard corporate governance practices for executive performance-based compensation and oversight.

Stakeholder Impact

  • Shareholders: This event signals that the company is meeting its internal operational goals, which can be viewed positively as it aligns executive compensation with performance.
  • Employees: May indicate a healthy performance culture if the operational targets are reflective of broader company success.

Next Steps

  • 50% of the acquired options will vest and become exercisable in March 2026.
  • The remaining 50% of the acquired options will vest and become exercisable in December 2026.

Key Dates

DateDescription
03/24/2022Original grant date of the stock option award.
12/11/2025Transaction date for the acquisition of 3,660 stock options.
12/15/2025Date the Form 4 filing was signed.
March 202650% of the 3,660 acquired options will vest and become exercisable.
December 2026The remaining 50% of the 3,660 acquired options will vest and become exercisable.
03/24/2032Expiration date of the stock option.

Recommendation

hold

This Form 4 indicates that Glaukos Corporation met certain operational targets, leading to the vesting of performance-based stock options for its SVP & CFO. While this is a positive sign for internal performance and executive alignment, it is a routine insider transaction and does not provide sufficient new information to warrant a change in investment recommendation. Investors should continue to hold based on broader company fundamentals and market conditions.

Keywords

Glaukos, GKOS, stock options, executive compensation, SEC Form 4, insider transaction, operational targets, vesting

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.